Intermittent ethanol access schedule in rats as a preclinical model of alcohol abuse S Carnicella, D Ron, S Barak Alcohol 48 (3), 243-252, 2014 | 335 | 2014 |
Disruption of alcohol-related memories by mTORC1 inhibition prevents relapse S Barak, F Liu, SB Hamida, QV Yowell, J Neasta, V Kharazia, PH Janak, ... Nature neuroscience 16 (8), 1111-1117, 2013 | 173 | 2013 |
Molecular mechanisms underlying alcohol-drinking behaviours D Ron, S Barak Nature Reviews Neuroscience 17 (9), 576-591, 2016 | 168 | 2016 |
Chromatin remodeling—a novel strategy to control excessive alcohol drinking V Warnault, E Darcq, A Levine, S Barak, D Ron Translational psychiatry 3 (2), e231-e231, 2013 | 152 | 2013 |
Corticostriatal BDNF and alcohol addiction ML Logrip, S Barak, V Warnault, D Ron Brain research 1628, 60-67, 2015 | 142 | 2015 |
mTOR complex 1: a key player in neuroadaptations induced by drugs of abuse J Neasta, S Barak, SB Hamida, D Ron Journal of neurochemistry 130 (2), 172-184, 2014 | 128 | 2014 |
Glial cell line-derived neurotrophic factor reverses alcohol-induced allostasis of the mesolimbic dopaminergic system: implications for alcohol reward and seeking S Barak, S Carnicella, QV Yowell, D Ron Journal of Neuroscience 31 (27), 9885-9894, 2011 | 98 | 2011 |
Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat MD Black, GB Varty, M Arad, S Barak, A De Levie, D Boulay, P Pichat, ... Psychopharmacology 202, 385-396, 2009 | 92 | 2009 |
AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side … MD Black, RJ Stevens, N Rogacki, RE Featherstone, Y Senyah, ... Psychopharmacology 215, 149-163, 2011 | 69 | 2011 |
Pro-cognitive and antipsychotic efficacy of the α7 nicotinic partial agonist SSR180711 in pharmacological and neurodevelopmental latent inhibition models of schizophrenia S Barak, M Arad, A De Levie, MD Black, G Griebel, I Weiner Neuropsychopharmacology 34 (7), 1753-1763, 2009 | 61 | 2009 |
Counterconditioning during reconsolidation prevents relapse of cocaine memories K Goltseker, L Bolotin, S Barak Neuropsychopharmacology 42 (3), 716-726, 2017 | 60 | 2017 |
The M1/M4 preferring agonist xanomeline reverses amphetamine-, MK801- and scopolamine-induced abnormalities of latent inhibition: putative efficacy against … S Barak, I Weiner International Journal of Neuropsychopharmacology 14 (9), 1233-1246, 2011 | 60 | 2011 |
Modeling cholinergic aspects of schizophrenia: focus on the antimuscarinic syndrome S Barak Behavioural brain research 204 (2), 335-351, 2009 | 57 | 2009 |
Putative cognitive enhancers in preclinical models related to schizophrenia: the search for an elusive target S Barak, I Weiner Pharmacology Biochemistry and Behavior 99 (2), 164-189, 2011 | 56 | 2011 |
SAR110894, a potent histamine H3-receptor antagonist, displays procognitive effects in rodents G Griebel, P Pichat, MP Pruniaux, S Beeské, M Lopez-Grancha, E Genet, ... Pharmacology Biochemistry and Behavior 102 (2), 203-214, 2012 | 50 | 2012 |
Scopolamine induces disruption of latent inhibition which is prevented by antipsychotic drugs and an acetylcholinesterase inhibitor S Barak, I Weiner Neuropsychopharmacology 32 (5), 989-999, 2007 | 50 | 2007 |
Escitalopram and NHT normalized stress-induced anhedonia and molecular neuroadaptations in a mouse model of depression O Burstein, M Franko, E Gale, A Handelsman, S Barak, S Motsan, ... PLoS One 12 (11), e0188043, 2017 | 48 | 2017 |
GDNF is a novel ethanol‐responsive gene in the VTA: implications for the development and persistence of excessive drinking S Ahmadiantehrani, S Barak, D Ron Addiction biology 19 (4), 623-633, 2014 | 48 | 2014 |
Nucleus accumbens-derived glial cell line-derived neurotrophic factor is a retrograde enhancer of dopaminergic tone in the mesocorticolimbic system J Wang, S Carnicella, S Ahmadiantehrani, DY He, S Barak, V Kharazia, ... The Journal of Neuroscience 30 (43), 14502-14512, 2010 | 45 | 2010 |
Towards an animal model of an antipsychotic drug-resistant cognitive impairment in schizophrenia: scopolamine induces abnormally persistent latent inhibition, which can be … S Barak, I Weiner International Journal of Neuropsychopharmacology 12 (2), 227-241, 2009 | 44 | 2009 |